Barrons

Published September 14, 2026

First Marijuana, Then Peptides. Why Psychedelics Are Wall Street's Next Big Trip. - Barron's

Read the full story at Barrons

Definium Therapeutics advances the case for medical LSD after reporting positive late-stage trial data for its experimental drug, DT120.